Columnar Cell

A columnar cell is a type of epithelial cell that is taller than it is wide, shaped like a column or pillar. These cells line many internal surfaces of the body, including parts of the airways, digestive tract, and certain glands, where they often play roles in absorption and secretion. Pathologists describe cell shape under the microscope as one clue to identifying what kind of tissue or tumor they are looking at.

Origin

The term comes from the Latin columna, meaning pillar, and entered medical use in the 19th century as histologists began classifying epithelial cells by shape (squamous, cuboidal, columnar) under the light microscope.

Significance in Asbestos Context

Cell shape matters in the pathology of asbestos-related cancers because mesothelioma and lung adenocarcinoma can both contain cells with columnar or column-like features, and distinguishing the two is critical for diagnosis, prognosis, and which treatments are offered. Epithelioid mesothelioma, the most common subtype, sometimes shows tubulopapillary patterns lined by columnar-appearing cells that can be mistaken for adenocarcinoma. Pathologists use immunohistochemistry (stains like calretinin, WT-1, BAP1, claudin-4, TTF-1, and CEA) to tell these apart. A clear, correct diagnosis affects not only your medical care but also the strength of your legal claim, since compensation programs and asbestos trusts require specific pathological confirmation of mesothelioma versus lung cancer.

Example Sentence

The pathology report described tumor cells with a columnar arrangement, prompting the doctors to order additional immunohistochemical stains to confirm whether the cancer was mesothelioma or a lung adenocarcinoma.

Related Terms

Epithelioid Mesothelioma, Adenocarcinoma, Immunohistochemistry, Histology, Tubulopapillary Pattern

Notes

• Ask your oncologist or pathologist whether your tumor was tested with a panel of mesothelioma markers (such as calretinin, WT-1, D2-40, and BAP1) and adenocarcinoma markers (such as TTF-1, claudin-4, and CEA). Relying on cell shape alone is not enough.
• If your diagnosis was based on a small biopsy, consider requesting a second pathology review at a mesothelioma specialty center; misclassification between mesothelioma and adenocarcinoma is well documented and can change both treatment and legal eligibility.
• Keep copies of the full pathology report, including the immunohistochemistry results and any descriptive language about cell shape and growth pattern. These documents are central to both medical care and any asbestos trust or lawsuit filing.